Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating ...

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GlaxoSmithKline (GSK) announced the purchase of 250,000 of its own ordinary ...

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has announced the purchase of 229,000 of its own ordinary shares as part of ...

GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.

Harvey Jones has been hunting for the best shares to buy for his SIPP, and found what he thinks is one in a surprising place.

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

FIDSON Healthcare Plc has reinforced its commitment to healthcare delivery, corporate governance, and strategic growth ...

UK pharma boss, Dame Emma Walmsley says why GSK's (GlaxoSmithKline) priority is the USA Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), ...